Yuemeng Jia

Dr. Yuemeng Jia

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Cell
Verified
Journal Article
Closed access
MZMin Zhu
Min Zhu
TLTianshi Lu
Tianshi Lu
YJYuemeng Jia
Yuemeng Jia
XLXin Luo
Xin Luo
PGPurva Gopal
Purva Gopal
HZHao Zhu
Hao Zhu

2 February 2016 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MBMihaela Babiceanu
Mihaela Babiceanu
Fujun QinFujun Qin
Fujun Qin
ZXZhongqiu Xie
Zhongqiu Xie
YJYuemeng Jia
Yuemeng Jia
KLKevin Lopez
Kevin Lopez
HLHui Li
Hui Li
Gene fusions and their products (RNA and protein) were once thought to be unique features to cancer. However, chimeric RNAs can also be found in normal cells. Here, we performed, curated and analyzed nearly 300 RNA-Seq libraries covering 30 different non-neoplastic human tissues and cells as well as 15 mouse tissues. A large number of fusion transcripts were found. Most fusions were detected only once, while 291 were seen in more than one sample. We focused on the recurrent fusions and performed RNA and protein level validations on a subset. We characterized these fusions based on various features of the fusions, and their parental genes. They tend to be expressed at higher levels relative to their parental genes than the non-recurrent ones. Over half of the recurrent fusions involve neighboring genes transcribing in the same direction. A few sequence motifs were found enriched close to the fusion junction sites. We performed functional analyses on a few widely expressed fusions, and found that silencing them resulted in dramatic reduction in normal cell growth and/or motility. Most chimeras use canonical splicing sites, thus are likely products of ‘intergenic splicing’. We also explored the implications of these non-pathological fusions in cancer and in evolution.

1 November 2017 in Cancer Cell
Verified
Journal Article
Closed access
XSXuxu Sun
Xuxu Sun
SWSam C. Wang
Sam C. Wang
YWYonglong Wei
Yonglong Wei
XLXin Luo
Xin Luo
YJYuemeng Jia
Yuemeng Jia
HZHao Zhu
Hao Zhu

25 October 2018 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
QCQIANG CHENG
QIANG CHENG
Tuo WeiTuo Wei
Tuo Wei
YJYuemeng Jia
Yuemeng Jia
LFLukas Farbiak
Lukas Farbiak
KZKejin Zhou
Kejin Zhou
DSDaniel Siegwart
Daniel Siegwart

1 September 2016 in Trends in Cancer
Verified
Journal Article
Closed access
YJYuemeng Jia
Yuemeng Jia
ZXZhongqiu Xie
Zhongqiu Xie
HLHui Li
Hui Li

14 June 2024 in Science
Verified
Journal Article
Closed access
XWXun Wang
Xun Wang
CMCameron J. Menezes
Cameron J. Menezes
YJYuemeng Jia
Yuemeng Jia
YXYi Xiao
Yi Xiao
SVSiva Sai Krishna Venigalla
Siva Sai Krishna Venigalla
PMPrashant Mishra
Prashant Mishra
Mitochondria are critical for proper organ function and mechanisms to promote mitochondrial health during regeneration would benefit tissue homeostasis. We report that during liver regeneration, proliferation is suppressed in electron transport chain (ETC)–dysfunctional hepatocytes due to an inability to generate acetyl-CoA from peripheral fatty acids through mitochondrial β-oxidation. Alternative modes for acetyl-CoA production from pyruvate or acetate are suppressed in the setting of ETC dysfunction. This metabolic inflexibility forces a dependence on ETC-functional mitochondria and restoring acetyl-CoA production from pyruvate is sufficient to allow ETC-dysfunctional hepatocytes to proliferate. We propose that metabolic inflexibility within hepatocytes can be advantageous by limiting the expansion of ETC-dysfunctional cells.